Sunday, March 26, 2017
BioDelivery Sciences Provides Corporate Update and Reports Fourth Quarter and Full-Year 2016 Financial Results
RALEIGH, N.C., March 17, 2017 /PRNewswire/ -- BioDelivery Sciences International, Inc. (BDSI) today reported financial results for the fourth quarter and full year ended December 31, 2016, and provided an update on recent business highlights and upcoming milestones.
Global intra-uterine contraceptive devices market is poised to grow at 3.5% till 2024, market reports by Data Bridge Market Research.
Global intra-uterine contraceptive devices market is expected to reach USD 4.9 billion by 2024 from USD 3.68 billion in 2013, at a CAGR of 3.5% in the forecast period 2...
Young researchers tackle Zika's unanswered questions
WASHINGTON, March 16, 2017 /PRNewswire-USNewswire/ -- A Maryland woman traveled to the Dominican Republic early in her pregnancy, spending three weeks with family. She felt dizzy and tired and, at first, attributed the lethargy to jet lag. Then, she experienced a rash that lasted about four da.....
Ultrasound Medical Devices Global Market - Forecast to 2023
LONDON, March 16, 2017 /PRNewswire/ -- "Ultrasound also known as diagnostic sonography, ultrasonography or sonogram is a kind of imaging technique/procedure that makes use of high-frequency sound waves for scanning and creating an image of body part (organs and structures inside the body). Compared to other imaging technologi.....
Gateway Health Announces Retirement Of Chief Medical Officer, Dr. Michael Madden
PITTSBURGH, March 16, 2017 /PRNewswire/ -- Gateway Health, a leading Medicaid and Medicare Advantage managed care organization (MCO), announced today that its Chief Medical Officer, Dr. Michael Madden, will retire from service in April 2017.   For more than a decade, Madden has held this importa.....
Canadian researchers join international fight against Zika
Government of Canada invests in three teams of Canadian and Latin American and Caribbean scientists to help address unanswered questions about Zika virus
Kadimastem Granted a Patent in the US for Treatment of Neurodegenerative Diseases
NESS ZIONA, Israel, March 16, 2017 /PRNewswire/ --

BioDelivery Sciences Announces Three Data Presentations on BELBUCA® at the American Academy of Pain Medicine 33rd Annual Meeting
RALEIGH, N.C., March 16, 2017 /PRNewswire/ -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced three data presentations from research surrounding BELBUCA® (buprenorphine) buccal film (CIII) at the American Academy of Pain Medicine (AAPM) 33rd Annual Meeting in Orlando, Flo.....
BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2016 Financial Results
LYNBROOK, N.Y., March 15, 2017 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase based-therapies with a first in class collagenase-based product collagenase clostridium histolyticum (CCH) marketed as XIAFLEX® in the U.S. .....


About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines